Reaching targets for mineral metabolism clinical practice guidelines and its impact on outcomes among Mexican chronic dialysis patients.

[1]  Keith C. Norris,et al.  Association of Cumulatively Low or High Serum Calcium Levels with Mortality in Long-Term Hemodialysis Patients , 2010, American Journal of Nephrology.

[2]  F. Tentori.  Opinion: Mineral and Bone Disorder and Outcomes in Hemodialysis Patients: Results from the DOPPS , 2010, Seminars in dialysis.

[3]  A. Macleod,et al.  Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD) , 2009 .

[4]  Supplemental Tables,et al.  KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). , 2009, Kidney international. Supplement.

[5]  P. Kerr,et al.  Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  S. Fukuhara,et al.  Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study , 2007, Diabetologia.

[7]  H. Tighiouart,et al.  Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  P. Bossuyt,et al.  Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  J. Bragg-Gresham,et al.  Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. , 2006, Kidney international.

[10]  G. Eknoyan,et al.  Improving outcomes for dialysis patients in the international Dialysis Outcomes and Practice Patterns Study. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[11]  F. Port,et al.  Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. , 2005, Kidney international.

[12]  F. Locatelli,et al.  Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  F. Port,et al.  Dose of dialysis: key lessons from major observational studies and clinical trials. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  Takashi Akiba,et al.  Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  C. Combe,et al.  Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  M. Kutner,et al.  The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  G. Eknoyan,et al.  The Dialysis Outcomes and Practice Patterns Study (DOPPS) and the Kidney Disease Outcomes Quality Initiative (K/DOQI): a cooperative initiative to improve outcomes for hemodialysis patients worldwide. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  G. Chertow,et al.  Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. , 2004, Journal of the American Society of Nephrology : JASN.

[19]  G. Deray,et al.  Herbs and the kidney. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  G. Eknoyan,et al.  Bone metabolism and disease in chronic kidney disease , 2003 .

[21]  Keith C. Norris,et al.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  J. Rastad,et al.  Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. , 2001, Surgery.

[23]  R. Wolfe,et al.  The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study , 2000 .

[24]  L. Lind,et al.  Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. , 1997, Journal of clinical epidemiology.

[25]  R. Brunkhorst,et al.  Calcium Kinetic Studies in Patients on Capd: Improvement of Secondary Hyperparathyroidism without Concomitant Improvement of Calcium Turnover , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[26]  P. Grützmacher,et al.  Differences in calcium kinetic pattern between CAPD and HD patients. , 1995, Clinical nephrology.

[27]  E. Slatopolsky,et al.  Effects of high concentrations of glucose on PTH secretion in parathyroid cells. , 1990, Kidney international.

[28]  R. Recker,et al.  Parathyroid and bone response of the diabetic patient to uremia. , 1984, Kidney international.

[29]  C. Christiansen,et al.  Hypoparathyroidism in diabetes mellitus. , 1981, Acta endocrinologica.